https://www.selleckchem.com/pr....oducts/crenolanib-cp
001). Conclusion In conclusion, this study showed that ISS provides significant prognostic information in MM patients with GFR ≥60 ml/min at the diagnosis. However, in patients with impaired renal function at the time of diagnosis, B2-microglobulin (B2M) may not be a good prognostic indicator since it may be affected by renal dysfunction as well as tumor burden.Background This paper adds to the series of systematic rapid living reviews, started in April 2020, to provide the rehabilitation community with updates on the latest
Tycka om
Kommentar
Dela med sig
